Integra Lifesciences Holdings (IART) EPS (Diluted) Growth (3y) (2012 - 2026)
Powered by 
Analysis
Integra Lifesciences Holdings (IART) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 33.46% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.07% |
| 10 | Integra Lifesciences Holdings | 1.25 Bn | 977.26 Mn | 219.74 Mn | 3.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.61% |
| Mar 31, 2026 | -30.14% |
| Dec 31, 2025 | -26.72% |
| Sep 30, 2025 | -28.42% |
| Jun 30, 2025 | -139.77% |
| Mar 31, 2025 | -41.74% |
| Dec 31, 2024 | -21.96% |
| Sep 30, 2024 | -31.55% |
| Jun 30, 2024 | -33.70% |
| Mar 31, 2024 | -27.64% |
| Dec 31, 2023 | -39.01% |
| Sep 30, 2023 | -13.81% |
| Jun 30, 2023 | 140.07% |
| Mar 31, 2023 | 40.16% |
| Dec 31, 2022 | 52.97% |
| Sep 30, 2022 | 56.83% |
| Jun 30, 2022 | 15.82% |
| Mar 31, 2022 | 0.93% |
| Dec 31, 2021 | 21.06% |
| Sep 30, 2021 | 48.64% |